The CD34+Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Sibling Donors Receiving Peripheral Blood Stem-Cells

被引：0
|
作者：
Floisand, Yngvar [1 ]
Mattsson, Jonas [2 ]
Ali, Maryan [3 ]
Gronvold, Bjorn [3 ]
Dybedal, Ingunn [3 ]
Myhre, Anders Eivind [3 ]
Abrahamsen, Ingerid Weum [3 ]
Tjonnfjord, Geir Erland [3 ]
Lundin, Katrin Ulrike [4 ]
Gedde-dahl, Tobias [3 ]
Remberger, Mats [5 ]
机构：
[1] Hematol, Oslo, Norway
[2] Univ Hlth Network, Allogene Blood & Marrow Transplant Program, Toronto, ON, Canada
[3] Oslo Univ Hosp, Hematol, Oslo, Norway
[4] Oslo Univ Hosp, Oslo, Norway
[5] Akad Univ Hosp, KFUE, Uppsala, Sweden
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
423
引用
收藏
页码：S279 / S279
页数：1
相关论文
共 50 条
  • [31] Relationship of CD 34+cell dose to hematopoietic recovery and transfusion requirements following autologous peripheral blood stem cell transplantation (PBSCT).
    Anguita, J
    Gómez-Pineda, A
    Ballesteros, M
    Serrano, D
    Diez-Martín, JL
    Pintado, T
    BLOOD, 1999, 94 (10) : 334B - 334B
  • [32] Evaluation of a high CD34(+) cell dose for hematopoietic stem cell transplantation.
    Rybka, WB
    Kiss, J
    Lister, J
    deMagalhaesSilverman, M
    Ball, ED
    BLOOD, 1996, 88 (10) : 1596 - 1596
  • [33] Peripheral blood CD34+ cell count as a predictor of adequacy of hematopoietic stem cell collection for autologous transplantation
    Combariza, Juan F.
    Barco, Gloria
    Estrada, Angela
    Jaramillo, Sergio
    Arango, Marcos
    IATREIA, 2016, 29 (04) : 424 - 432
  • [34] Method comparison between hematopoietic progenitor cell and CD34+cell counts in hematopoietic stem cell collection
    Lavalleye, Thibault
    Saussoy, Pascale
    Lambert, Catherine
    TRANSFUSION, 2024, 64 (09) : 1743 - 1751
  • [35] CD34+ selected cells in mismatched stem cell transplantation:: a single centre experience of haploidentical peripheral blood stem cell transplantation
    Bunjes, D
    Duncker, C
    Wiesneth, M
    Stefanic, M
    Dohr, D
    Harsdorf, S
    Karakas, T
    Reske, SN
    Bergmann, L
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S9 - S11
  • [36] CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation
    D Bunjes
    C Duncker
    M Wiesneth
    M Stefanic
    D Dohr
    S Harsdorf
    T Karakas
    SN Reske
    L Bergmann
    Bone Marrow Transplantation, 2000, 25 : S9 - S11
  • [37] Impact of CD34+stem cell dose on early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, A.
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D.
    Junghanss, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S567 - S567
  • [38] Peripheral blood stem cell transplantation in myeloma using CD34 selected cells
    Johnson, RJ
    Owen, RG
    Smith, GM
    Child, JA
    Galvin, M
    Newton, LJ
    Rawstron, A
    Major, K
    Woodhead, V
    Robinson, F
    Jack, A
    Morgan, GJ
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 723 - 727
  • [39] Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+cell dose
    Sorigue, Marc
    Sancho, Juan-Manuel
    Morgades, Mireia
    Moreno, Miriam
    Grifols, Juan-Ramon
    Alonso, Eva
    Junca, Jordi
    Ferra, Christelle
    Batlle, Montserrat
    Vives, Susana
    Motllo, Cristina
    Garcia-Caro, Montserrat
    Navarro, Jose-Tomas
    Milla, Fuensanta
    Feliu, Evarist
    Ribera, Josep-Maria
    LEUKEMIA & LYMPHOMA, 2017, 58 (04) : 916 - 922
  • [40] Addition of plerixafor for CD34+cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation
    Hauge, Anne Werner
    Haastrup, Eva Kannik
    Sengelov, Henrik
    Minulescu, Lia
    Dickmeiss, Ebbe
    Fischer-Nielsen, Anne
    TRANSFUSION, 2014, 54 (04) : 1055 - 1058
12345